Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Merck & Co (NY: MRK)
72.57 USD  +0.22 (+0.30%)
Official Closing Price  /  Updated: 6:53 PM EDT, Oct 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 11,914,300
Open 72.97
Bid (Size) 71.29 (1)
Ask (Size) 72.98 (1)
Prev. Close 72.35
Today's Range 71.85 - 73.49
52wk Range 52.83 - 73.49
Shares Outstanding 2,690,303,898
Dividend Yield 2.63%
Performance
YTD
+29.08%
+29.08%
1 Month
+2.53%
+2.53%
3 Month
+15.76%
+15.76%
6 Month
+20.45%
+20.45%
1 Year
+14.46%
+14.46%
Top News
More News
Merck’s KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival Compared to Standard of Care, as Monotherapy and in Combination with Chemotherapy, as First-Line Treatment for Patients with Re
KEYTRUDA Significantly Improved OS Compared to Standard of Care, as Monotherapy and in Combination w/Chemotherapy, as First-Line Treatment for HNSCC Read More
from Business Wire News Releases
European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Melanoma
European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® as Adjuvant Therapy in Melanoma Read More
from Business Wire News Releases
More News
Read More
NetworkNewsBreaks – Patient Dosing Underway in BriaCell Therapeutics’ (TSX.V: BCT) (OTCQB: BCTXF) Combination Study with KEYTRUDA® and YERVOY®
from NetworkNewsWire
SOLO-1 Phase 3 Trial Demonstrates LYNPARZA® (olaparib) Maintenance Therapy Cut the Risk of Disease Progression or Death by 70 Percent in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Ca
from Business Wire News Releases
Why Aduro Biotech Crashed 29.5% Today
category MRK , Market News , ADRO , and 2 more.
from Motley Fool
2018 Dogs Of The Dow
category Stocks / Equities
from Blogs - TalkMarkets
Why Tesaro, Inc. Is Tanking Today
category TSRO , Market News , MRK , and 1 more.
from Motley Fool
These Companies Are Dragging Biotech Stocks Into A Pit On Cancer Tests
from Investor's Business Daily
These Companies Are Dragging Biotech Stocks Into A Pit On Cancer Tests
from Investor's Business Daily
Here's Why Clovis Oncology Dropped as Much as 21.2% Today
category MRK , Market News , AZN , and 1 more.
from Motley Fool
Here's Why ImmunoGen Fell Today
category Market News , IMGN , MRK
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.